GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹7,157 Cr | ₹6,788 Cr | ₹6,015 Cr | ₹5,234 Cr | ₹4,023 Cr |
What is the latest Profit & Loss Account Balance ratio of GLAND PHARMA ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2025 | ₹7,157 Cr |
| Mar2024 | ₹6,788 Cr |
| Mar2023 | ₹6,015 Cr |
| Mar2022 | ₹5,234 Cr |
| Mar2021 | ₹4,023 Cr |
How is Profit & Loss Account Balance of GLAND PHARMA Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2025 | ₹7,157 Cr | 5.44 | |
| Mar2024 | ₹6,788 Cr | 12.84 | |
| Mar2023 | ₹6,015 Cr | 14.92 | |
| Mar2022 | ₹5,234 Cr | 30.12 | |
| Mar2021 | ₹4,023 Cr | - | |
Compare Profit & Loss Account Balance of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹28,856.5 Cr | 2.1% | 1.3% | 19.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,848.0 Cr | 11.6% | 0.7% | -0.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,697.0 Cr | 2.3% | 8.5% | 8.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,859.0 Cr | 1.8% | -1.8% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,421.0 Cr | 0.5% | 3.2% | 13.3% | Stock Analytics | |
| CIPLA | ₹105,811.0 Cr | 1.2% | 5.4% | -13.7% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 2.1% |
1.3% |
19.7% |
| SENSEX | -1% |
2.2% |
-3.6% |
You may also like the below Video Courses